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PE_PGRS33 is a surface-exposed protein of Mycobacterium tuberculosis (Mtb) which
exerts its role in macrophages entry and immunomodulation. In this study, we aimed
to investigate the polymorphisms in the pe_pgrs33 gene of Mtb clinical isolates and
evaluate their impact on protein functions. We sequenced pe_pgrs33 in a collection of
135 clinical strains, genotyped by 15-loci MIRU-VNTR and spoligotyping and belonging
to the Mtb complex (MTBC). Overall, an association between pe_pgrs33 alleles and
MTBC genotypes was observed and a dN/dS ratio of 0.64 was obtained, suggesting
that a purifying selective pressure is acting on pe_pgrs33 against deleterious SNPs.
Among a total of 19 pe_pgrs33 alleles identified in this study, 5 were cloned and used
to complement the pe_pgrs33 knock-out mutant strain of Mtb H37Rv (Mtb133) to
assess the functional impact of the respective polymorphisms in in vitro infections of
primary macrophages. In human monocyte-derived macrophages (MDMs) infection,
large in-frame and frameshift mutations were unable to restore the phenotype of Mtb
H37Rv, impairing the cell entry capacity of Mtb, but neither its intracellular replication
rate nor its immunomodulatory properties. In vivo studies performed in the murine
model of tuberculosis (TB) demonstrated that the Mtb133 mutant strain was not
impaired in the ability to infect and replicate in the lung tissue compared to the parental
strain. Interestingly, Mtb133 showed an enhanced virulence during the chronic steps
of infection compared to Mtb H37Rv. Similarly, the complementation of Mtb133 with a
frameshift allele also resulted in a Mtb strain capable of causing a surprisingly enhanced
tissue damage in murine lungs, during the chronic steps of infection. Together, these
results further support the role of PE_PGRS33 in the pathogenesis and virulence ofMtb.
Keywords: Mycobacterium tuberculosis, PE_PGRS, genetic variability, polymorphisms, bacterial pathogenesis,
host-pathogen interactions
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INTRODUCTION
Mycobacterium tuberculosis (Mtb), the main etiological agent of
tuberculosis (TB) in humans, still represents one of the most
feared pathogens at global level, with 10.4 million new cases of
TB and 1.4 million deaths in 2015 (World Health Organization,
2016). According to recent comparative genomic studies, Mtb
originated in Africa between 70,000 and 35,000 years ago from
a genetic bottleneck of its progenitor (Gutierrez et al., 2005;
Hershberg et al., 2008; Wirth et al., 2008), followed by the clonal
expansion of 7 genetically homogeneous Mtb complex (MTBC)
superlineages that ravaged human communities for centuries
(Portevin et al., 2011; Gagneux, 2012; Firdessa et al., 2013).
The evolutionary scenario currently accepted for MTBC
advocates the pathogen coevolution with different human
populations and its association with specific geographical regions
(Gagneux and Small, 2007; Hershberg et al., 2008; Wirth
et al., 2008; Comas et al., 2013). Four MTBC superlineages
were referred to as ancient and are mainly found in Eastern
and Western Africa, South Eastern Asia and Southern India;
the remaining three superlineages, denominated modern, are
globally widespread and are responsible for the gravest TB
epidemics in modern history (Gagneux, 2012; Firdessa et al.,
2013). Despite the genetic homogeneity shared by MTBC
superlineages compared to other bacterial pathogens, the
presence of small sequence variations in MTBC genome is
nevertheless responsible for differential pathogenetic properties
(Gagneux and Small, 2007; Portevin et al., 2011).
It was hypothesized that most of the sequence variability
among these genetically homogeneous bacteria rested on two
large gene families, pe and ppe, covering approximately 7% of
the Mtb genome coding capacity and encoding surface-exposed
proteins (Cole et al., 1998; Banu et al., 2002; Brennan and Delogu,
2002; Mukhopadhyay and Balaji, 2011; Fishbein et al., 2015).
The PE_PGRS and PPE_MPTR protein subfamilies, which are
the most recently evolved within the respective families, are
characterized by the presence of polymorphic regions at their
C-terminus that vary in sequence and size (Gey van Pittius
et al., 2006; McEvoy et al., 2012). pe_pgrs genes show GC-
rich repetitive sequences (PGRS) which encode Gly-Gly-Ala/X
repeats and ppe_mptr genes present polymorphic tandem repeats
(MPTR) encoding Asn-(X-Gly)2-X-Asn-X-Gly repeats (Poulet
and Cole, 1995; Sampson, 2011; Soldini et al., 2011; McEvoy et al.,
2012).
One of the most investigated members of the pe_pgrs gene
subfamily, the pe_pgrs33 gene, was shown to be polymorphic
amongMTBC clinical strains, with SNPs andmore frequently in-
frame indels occurring in the PGRS domain of the protein and
resulting in the gain/loss of one or more Gly-Gly-Ala/X repeats
(Talarico et al., 2005, 2007; Wang et al., 2011; McEvoy et al.,
2012). These findings provided an experimental support to the
possible involvement of PE_PGRS33, as well as other PE_PGRS
proteins, in the antigenic variability of Mtb (Talarico et al., 2005,
2007). Nevertheless, a recent study questioned this hypothesis in
favor of the evolutionary conservation of the pe_pgrs33 gene as
indicated by the surprisingly low dN/dS ratio calculated taking
into account 95 MTBC clinical strains (Copin et al., 2014).
To date, pe_pgrs33 alleles showing frameshift or large in-frame
indels have been associated with non-cavitary pulmonary TB or
extrapulmonary TB in children (Talarico et al., 2007; Wang et al.,
2011), though the actual implications of these genetic variations
on the pathogenesis and virulence of Mtb have not yet been
explored.
In this study, we investigated for the first time the
impact of polymorphisms occurring in pe_pgrs33 alleles among
Mtb clinical isolates in terms of pathogenesis and virulence,
by exploiting complementation of the recently characterized
pe_pgrs33 mutant strain of Mtb H37Rv (Mtb133) (Palucci
et al., 2016). Based on previous evidences which implicated
PE_PGRS33 in the pathogenesis of Mtb (Brennan et al., 2001;
Palucci et al., 2016) and supported its role in mediatingMtb entry
into macrophages and triggering of inflammatory responses
in a TLR2-dependent mechanism (Brennan et al., 2001; Basu
et al., 2007; Zumbo et al., 2013), here we assessed whether and
how natural genetic variations may affect the functionality of
PE_PGRS33 in in vitro and in vivomodels of TB.
MATERIALS AND METHODS
MTBC Strains, Mycobacterial Cultures and
DNA Extraction
One hundred thirty-five MTBC clinical strains were randomly
selected from a collection of MTBC strains isolated at the
Catholic University of the Sacred Heart in Rome between 2007
and 2011. Each clinical isolate was grown in Middlebrook 7H9
medium supplemented with 0.2% glycerol, 10% ADC and 0.05%
Tween 80 at 37◦C. Genomic DNA was extracted from liquid
cultures by using the CTABmethod, as previously described (van
Embden et al., 1993).
Molecular Typing and Phylogenetic
Analysis of MTBC Strains
The genomic DNA of each MTBC clinical strain was genotyped
by 15-loci MIRU-VNTR method (Gutierrez et al., 2005) and
spoligotyping (Kamerbeek et al., 1997), as previously described.
For MIRU-VNTR typing, each multiplex PCR set included the
genome of Mtb H37Rv and water, as positive and negative
controls, respectively. Similarly, in each experimental session of
spoligotyping, both genomes of Mtb H37Rv and M. bovis BCG
were used as positive controls and water as negative control.
All multiplex PCRs for MIRU-VNTR typing were analyzed by
capillary electrophoresis by using Applied Biosystems 3130xl
Genetic Analyzer and PCR fragments size was estimated with
the GeneMapper 4.0 software (Applied Biosystems). On MIRU-
VNTRplus database, where possible, best-matches based on
similarity search were inferred to the 15-loci MIRU-VNTR and
spoligotyping patterns by setting a distance cut-off of 0.4, then a
tree-based identification was performed by using default distance
measures (www.miru-vntrplus.org; Gutierrez et al., 2005; Allix-
Béguec et al., 2008). AUPGMA tree was eventually generated and
rooted to the two reference strains ofM. canettii available on the
database.
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Sequencing of pe_pgrs33 Alleles and Data
Analysis
The pe_pgrs33 gene from each MTBC clinical strain was
amplified with two primers previously described, PE_PGRS33-
F1 and PE_PGRS33-R1 (Wang et al., 2011; Supplementary Table
1), by using the Expand High Fidelity PCR System (Roche)
kit. Sanger sequencing was performed in Applied Biosystems
3130xl Genetic Analyzer. All identified polymorphisms were
confirmed by double-strand DNA sequencing, as previously
described (Talarico et al., 2005; Supplementary Table 1). Each
DNA sequence was assembled respect to pe_pgrs33 of Mtb
H37Rv by using SeqMan (Lasergene 7). The genetic relationships
between the 19 pe_pgrs33 alleles identified in this study were
investigated using MEGA version 6 (Tamura et al., 2013), by
inferring a Maximum Likelihood tree under HKY model and
setting 1000 bootstrap resampling. The selective pressure acting
on all pe_pgrs33 alleles was evaluated by calculating the dN/dS
ratio with DnaSP (Rozas et al., 2003).
Cloning of pe_pgrs33 Alleles and Protein
Expression
Five of the 19 pe_pgrs33 alleles identified in this study and
their native promoters were amplified from the genome of one
respective MTBC clinical isolate with two primers previously
described, PG335Hn-338bp and 18c3AXb (Palucci et al., 2016;
Supplementary Table 1), by using the Expand High Fidelity PCR
System (Roche) kit. Each pe_pgrs33 allele under the control of its
native promoter was cloned into the integrative plasmid pMV306
in-frame with the HA epitope sequence (Palucci et al., 2016).
The previously generated Mtb133 mutant strain (Palucci et al.,
2016) was then complemented with all constructs, according to
procedures already described (Cascioferro et al., 2011; Palucci
et al., 2016). To assess PE_PGRS33 expression, recombinant
mycobacterial mid-log phase cells were homogenized in lysis
buffer (10 mM Tris-HCl, 5 mM EDTA, protease inhibitors
cocktail, pH 9.5) and 0.1 mm zirconia/silica beads (Biospec
Products), as previously described (De Maio et al., 2014). Protein
lysates, devoid of cellular debris and unlysed cells, were separated
by SDS-PAGE on 12% polyacrylamide gels and were then
transferred to nitrocellulose membrane by western blot. HA-
tagged PE_PGRS33 was detected by using anti-HA monoclonal
antibody HA.11 (1:1,000) (Covance), as primary antibody, and
anti-mouse IgG peroxidase conjugate (1:4,000) (Sigma-Aldrich,
Saint Louis, MO), as secondary antibody. Since, as expected, the
protein encoded by 33all3 was undetectable by western blot, two
control PCRs were carried out by using the genomic DNA ofMtb
H37Rv and the pMV306 plasmid engineered with the 33all3 allele
under the control of its native promoter (subsequently used to
complement theMtb133 mutant) as positive controls and water
as negative control (Supplementary Figure 1; Supplementary
Table 1). As further control, polymorphisms in 33all3 of the
Mtb133::33all3 strain were reconfirmed by Sanger sequencing
(data not shown).
Cell Cultures and In vitro Infections
Mice manipulation was performed prior approval by the Ethics
Committee of the Catholic University of the Sacred Heart
in Rome (Prot. Number: n◦ T21/2011). Peritoneal murine
macrophages (pMMOs) were isolated from 9 to 14 weeks old
female C57BL/6 mice (Harlan), as previously described (Palucci
et al., 2016). pMMOs were seeded at 1.2·106cells/ml in 48-
well plates in RPMI medium supplemented with 10% FBS
and 1% of both L-glutamine and sodium pyruvate and were
incubated overnight at 37◦C in a 5% humidified atmosphere.
After removing non-adherent cells, pMMOs were infected for
1 h with Mtb strains at a multiplicity of infection (MOI) of
1:10 and then incubated in complete RPMI medium. Four
hours later, intracellular mycobacteria were determined by CFUs
enumeration, as previously described (Palucci et al., 2016).
Buffy coats of 4 male donors were processed to collect human
peripheral blood mononuclear cells (PBMCs) and monocyte-
derived macrophages (MDMs). PBMCs were isolated from buffy
coats by using Ficoll, seeded for mycobacterial infections at
1.2·106 cells/ml in 48-well plates in X-VIVOTM 15 medium
(Lonza) with human serum type AB 2% (Lonza) and incubated
overnight at 37◦C in a 5% humidified atmosphere. MDMs were
isolated by positive selection from unplated PBMCs by using
CD14 MicroBeads, following the manufacturer’s instructions
(Miltenyi Biotec). MDMs were seeded at 1.2·106 cells/ml in 48-
well plates, as indicated for PBMCs and were incubated for 6–
7 days at 37◦C in a 5% humidified atmosphere until MDM
differentiation. Both PBMCs and MDMs were infected withMtb
strains at a MOI of 1:1. According to the method described
above for pMMOs, MDMs were infected and intracellular
mycobacterial CFUs were determined at 4 and 72 h post-infection
(Palucci et al., 2016). For PBMCs infections, mycobacterial
inocula at a MOI of 1:1 were directly added to cell culture
supernatants and at 72 h post-infection total mycobacterial CFUs
were enumerated (Palucci et al., 2016). Specifically, cell pellets
obtained prior centrifugation of supernatants from PBMCs
infection were lysed and resuspended in PBS with 0.05% Tween
80, where MDMs lysed in 0.1% Triton X-100 were previously
added, then total lysates were serially diluted and plated on
7H11/OADC agar medium (Palucci et al., 2016). Supernatants
from PBMCs and MDMs at 72 h post-infection were collected
and stored a−80◦C until being assayed for cytokine ELISA.
Cytokine Analysis
Supernatants collected from MDMs and PBMCs at 72 h post-
infection were filtered to remove mycobacteria and cytokines
were analyzed by using a Cytometric Bead Array (CBA) (BD
Biosciences, San Jose, USA) and a FACS CANTO II (BD
Biosciences, San Jose, USA), according to the manufacturer’s
instructions. CBA results were generated by FCAP ArrayTM
software (BD Biosciences, San Jose, USA). For supernatants
collected from PBMCs at 72 h post-infection, IFN-γ release was
also evaluated by using ELISA QuantiFERON TB-Gold (Qiagen,
Hilden, Germany), according to the manufacturer’s instructions.
In vivo Infection
Animal studies were carried out in strict accordance with the
Amsterdam protocol on animal protection and welfare, the
Directive 2010/63/EU of the European Parliament and the
Council of 22 September 2010 on the protection of animals
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used for scientific purposes and the French Decree 2013-118.
The protocol was approved by the Minister of Higher Education
and Research after favorable opinion of the Ethics Committee
(CEEA Nord-Pas de Calais/INSERMU1019 n◦ 00579.01 from
23/07/2014). All efforts were made to minimize suffering of
the animals. Six-weeks-old female BALB/c mice (Janvier) were
challenged with mycobacterial strains via the intranasal route
with 10 µl/nostril. Challenge suspensions were adjusted in order
to obtain an inhaled dose of approximately 1,000 CFU/lungs.
At day 0, 28, and 49 post-infection, lungs from euthanized
mice were collected and homogenized by using an MM300
apparatus (Qiagen) and 2.5-mm diameter glass beads. Ten-fold
serial dilutions of lung homogenates were plated on 7H11/OADC
agar medium and CFUs enumerated, as previously described
(Palucci et al., 2016).
Histopathological Analysis
Murine lungs were fixed with 10% paraformaldehyde and then
embedded in paraffin for sectioning, according to standard
methods. In order to correlate the presence of histologic lesions
with acid-fast bacilli (AFB), replicas 3 µm sections were cut
and stained with both Haematoxyline and Eosin (HE) and
Ziehl–Neelsen (ZN), following standard techniques. The lesions
morphology and distribution were evaluated by lightmicroscopy.
At least 6 lung sections for all mice of the 5 groups were
analyzed in different points (24 lung sections per experimental
group in total). For each section the number of ZN positive
cells, the total surface area and the area with lesions were
measured at 400x magnification and averages calculated for each
section and group. Slides were imaged using Nikon Eclipse
80i microscope and digital computer images were recorded
with a Nikon DS-L2 camera control unit and the Nikon
dedicated software 3422.1001.1798.080117. Cellular automatic
count and histological measurements were carried out using
the dedicated software Axiovision ver. 4.4 (Zeiss) by two
independent researchers on two independent photo series.
Immunological Colocalization
This assay was carried out by using two monoclonal antibodies
(mAb), purified biotin anti-F4/80 Clone BM8 (Caltag Labs,
cat. n. MF48000) and purified anti-MT 16 kDa antigen (Santa
Cruz Biotechnology, cat. n. sc-58169). Signals were revealed
with Streptavidin Alexa Fluor R© 555 and Streptavidin Alexa
Fluor R© 488. For immunomicroscopy, slides obtained from
fixed-lung tissues were also processed, as previously described,
and mounted on positively charged Superfrost slides (Fisher
Scientific). Deparaffinization, rehydration and antigens retrieval
of tissue sections were performed by using Dewax and HIER
Buffer L (Thermo Fisher Scientific). To prevent non-specific
bindings, slides were incubated in PBS containing 2% BSA,
stabilizing protein and 0.015 mol/L sodium azide (Protein
Block Serum-Free, Dako). For each target, tissue sections were
incubated in two different steps with primary mAb (overnight
at 4◦C), Ab (1 h at room temperature) and the respective
fluorophore. Slides were counterstained with Hoechst blue and
then covered. Images were acquired by using a Leica TCS
SP 5 confocal microscope (Leica Microsystems, Germany) and
processed with LAS AF Lite application software developed by
Leica Microsystems CMS GmbH for contrast and brightness
adjustments. Negative controls prepared by omission of primary
antibodies did not show any fluorescence under the conditions
described above.
Statistical Analysis
Experiments were conducted in triplicate and replicated at
least three times. In vivo experiment was performed one time
in quintuplicate. Statistical analysis was performed by using
GraphPad Prism version 6 (GraphPad software, CA, USA). For
pMMOs infections, CFUs were expressed as mean ± SD and
analyzed by one-way ANOVA, followed by Dunnett’s multiple
comparison test. For infections of human PBMCs and MDMs,
results concerning CFUs and cytokine levels were expressed
as median and analyzed by Kruskal-Wallis one-way ANOVA,
followed by Dunnett’s multiple comparison test. Results obtained
from in vivo experiments were expressed as mean ± SD
and analyzed by performing two-way ANOVA, followed by
Dunnett’s multiple comparison test. Histopathological results
were analyzed by Student’s t-test.
RESULTS
Superlineage-Based Composition and
Phylogeny of 135 MTBC Clinical Strains
Collected in Rome
One hundred thirty-five MTBC clinical strains isolated in Rome
from 2007 to 2011 were genotyped by using 15-loci MIRU-
VNTR (Gutierrez et al., 2005) combined with spoligotyping
(Kamerbeek et al., 1997). The in silico analysis performed
on MIRU-VNTRplus database (Gutierrez et al., 2005; Allix-
Béguec et al., 2008) allowed to identify 125 isolates (92.6%)
and assign the respective MTBC superlineage (Supplementary
Figure 2). The majority of isolates (104 isolates, 77%) belonged
to the modern MTBC superlineages, which comprised the
superlineages 2 (East-Asian, 2 isolates, 1.5%), 3 (East-African
Indian, 7 isolates, 5.2%) and 4 (Euro-American, 95 isolates,
70.4%). This latter was composed of the Cameroon (4 isolates,
4.2%), Haarlem (39 isolates, 41.1%), LAM (11 isolates, 11.6%),
S (12 isolates, 12.6%), Uganda I (4 isolates, 4.2%), Uganda II
(1 isolate, 1.1%), X (2 isolates, 2.1%) lineages and unassigned
strains (22 isolates, 23.2%, indicated in Supplementary Figure
2 as “?”) which could plausibly belong to the T-specific lineage
of the Euro-American superlineage (Allix-Béguec et al., 2008).
Although to a lesser extent (21 isolates, 15.6%), our collection
of MTBC strains embraced three ancient superlineages: the most
representative was the superlineage 1 (Indo Oceanic, 17 isolates,
12.6%), followed by the superlineages 5 and 6 (West African
1 and West African 2, respectively, 1 isolate, 0.7% each) plus
the animal superlineage (2 isolates, 1.5%). The phylogenetic
relationships between all 135 genotyped MTBC clinical strains
were inferred by constructing an UPGMA tree rooted by two
reference strains of M. canettii on MIRU-VNTRplus database
(Figure 1; Gutierrez et al., 2005; Allix-Béguec et al., 2008).
According to the phylogeographical distribution described for
the MTBC by Gagneux and colleagues (Gagneux, 2012), our
results showed how all MTBC superlineages are represented in
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FIGURE 1 | Phylogeny of 135 MTBC clinical strains color-coded by the
pe_pgrs33 alleles. One hundred thirty-five MTBC clinical strains isolated in
Rome were genotyped by 15 loci MIRU-VNTR (Gutierrez et al., 2005)
combined with spoligotyping (Kamerbeek et al., 1997). An UPGMA tree rooted
by two previously characterized strains of M. canetti was obtained from
MIRU-VNTRplus database (Gutierrez et al., 2005; Allix-Béguec et al., 2008)
and a different color-coded by the pe_pgrs33 alleles was assigned. Gray dot,
unknown strains; “?,” strains likely belonging to the T-specific lineage of the
Euro-American superlineage (Allix-Béguec et al., 2008).
the metropolitan area of Rome, except for the recently described
ancient superlineage denominated 7 or Ethiopian (Firdessa et al.,
2013), and that the Euro-American superlineage is the most
prevalent.
MTBC Clinical Strains and pe_pgrs33
Alleles Association
The genetic variability of the pe_pgrs33 gene within the MTBC
population analyzed in this study was assessed by Sanger
sequencing. As shown in Supplementary Table 2, a total of 19
pe_pgrs33 alleles were identified. Apart from the allele referred
to as 11, which corresponded to pe_pgrs33 of Mtb H37Rv and
was found in 42 MTBC clinical isolates (Figure 1), we identified
11 alleles previously described in literature (Talarico et al., 2005,
2007; Wang et al., 2011; McEvoy et al., 2012) and 7 alleles
containing new genetic variations (alleles 3, 7, 8, 9, 14, 16, and
17) compared to pe_pgrs33 of the H37Rv reference strain. Among
all pe_pgrs33 alleles, we identified a total of 13 SNPs (9 non-
synonymous and 4 synonymous), mainly occurring in the PGRS
region. All indel events were exclusively located in the PGRS
domain, the majority of which were in-frame and varied from a
minimum of 9 bp to a maximum of 72 bp. The largest mutations
were in-frame deletions found in 11 EAI isolates (allele 1), in
the only isolate ofM. africanum belonging to the West African 1
superlineage (allele 6) and in all the 7 Delhi/CAS isolates (alleles
18 and 19) (Figure 1). The only frameshift mutation identified
was 1 bp deletion in position 1,014 bp and was detected in 3
pe_pgrs33 alleles (alleles 1, 2, and 3) all belonging to the EAI
superlineage (Figure 1). Specifically, the altered frame in these
latter alleles results in the introduction of a premature stop
codon, which translates into the loss of the last 160 amino acids
from the C-terminal of the PGRS domain and the “acquisition” of
a 36-amino acids stretch, rich in proline residues (approximately
20%) and short antigenic epitopes, as revealed by the in silico
antigenicity prediction of the protein (Supplementary Figure 3).
The 3 pe_pgrs33 alleles, sharing the only frameshift mutation
identified in this study, were more evolutionarily distant from the
other alleles in the unrooted tree shown in Supplementary Figure
4. Moreover, a strict association between these alleles and the
EAI superlineage was revealed by the 15-loci MIRU-VNTR and
spoligotyping-based UPGMA tree color-coded by the pe_pgrs33
alleles (Figure 1). Similarly, a “clustered” association within the
MTBC superlineages was quite fulfilled in the same tree also for
the other alleles. In agreement with the results of Copin et al.
(2014), the dN/dS ratio of 0.64 obtained for the pe_pgrs33 alleles
identified in this study supports the evidence that a purifying
selection is acting on pe_pgrs33 to preserve the gene sequence
from deleterious SNPs.
pe_pgrs33 Alleles and Protein Expression
Until recently, a possible role of PE_PGRS33 in the antigenic
variability of Mtb has been entrenched with the identification
of numerous polymorphisms in the pe_pgrs33 gene among
Mtb clinical isolates (Talarico et al., 2005, 2007; Wang et al.,
2011; McEvoy et al., 2012). However, a recent study questioned
this hypothesis, suggesting an ongoing purifying selection on
pe_pgrs33 and a limited impact on the functionality and
antigenicity of PE_PGRS by indel events occurring in the PGRS
domain (Copin et al., 2014). To elucidate the biological meaning
of natural polymorphisms occurring in pe_pgrs33 and their
impact on the pathogenesis and virulence of Mtb, 5 of the 19
pe_pgrs33 alleles identified in this study, designated from here
as 33allx (where “x” referred to the number of the respective
allele), were selected based on the heterogeneity of their genetic
variations. Among the selected alleles, 4 (33all3, 33all5, 33all6, and
33all18) were characterized by SNPs, in-frame indels and a single
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frameshift deletion occurring in the region encoding the PGRS
domain of PE_PGRS33 compared to the 33all11 allele, which
corresponds to pe_pgrs33 of Mtb H37Rv (Table 1; Figure 2A).
Moreover, no polymorphisms were detected in the native
promoter sequence of the 5 pe_pgrs33 alleles used in this study.
These alleles were cloned in the integrative plasmid pMV306,
under the control of their native promoter and upstream the
HA epitope sequence, and all plasmids used to complement the
previously generatedMtb133 mutant strain (Palucci et al., 2016;
Figure 2). Transcriptional analysis by RT real-time PCRwas used
to confirm expression in the complemented strains and higher
expression of pe_pgrs33 was observed in the complemented
strains compared to the wild type (+2,5-fold, data not shown),
as expected when the gene is inserted in the attB site following
complementation with the integrative plasmid pMV306 (Palucci
et al., 2016). Apart from Mtb133::33all3, for all complemented
strains, PE_PGRS33 expression was assessed on protein lysates
by western blot using an anti-HA antibody (Figure 2B). For
Mtb133::33all3, PCR (Supplementary Figure 1) and Sanger
sequencing (data not shown) allowed to confirm both strain
complementation and the altered frame in 33all3.
The Altered Frame of pe_pgrs33 Negatively
Affects the Protein-Mediated Entry of Mtb
into Murine Macrophages
In previous studies, large in-frame sequence variations in the
pe_pgrs33 gene were associated to peculiar epidemiological
phenotypes, like non-cavitary pulmonary TB or extrapulmonary
TB in children (Talarico et al., 2005, 2007; Wang et al.,
2011). To investigate the pathogenic impact of large sequence
variations occurring in pe_pgrs33 among MTBC clinical isolates,
peritoneal murine macrophages (pMMOs) were infected at
a MOI 1:10 with the Mtb H37Rv, Mtb133 mutant and
complemented strains with all 5 pe_pgrs33 alleles selected
in this study (Mtb133::33all11, Mtb133::33all3, Mtb133::33all5,
Mtb133::33all6, and Mtb133::33all18). Since we recently showed
that the Mtb133 mutant is impaired in its ability to enter into
macrophages (Palucci et al., 2016), the capacity to restore this
phenotype by the complemented strains was assessed at 4 h post-
infection by enumerating intracellular CFUs (Figure 3). Similar
to theMtb133::33all11 strain,Mtb133::33all5,Mtb133::33all6, and
Mtb133::33all18 were able to entry into pMMOs as efficiently
as the parental strain. The significant reduction in this capacity
for the Mtb133 mutant (p < 0.01) was also markedly observed
for Mtb133::33all3 (p < 0.001), indicating that whilst frameshift
mutation in pe_pgrs33 alleles impair the cell entry phenotype
of Mtb, small and large in-frame sequence variations as well as
nsSNPs do not affect the PE_PGRS33-mediated entrance of Mtb
into murine macrophages.
Large Sequence Variations Occurring in
pe_pgrs33 Alleles Impair Mtb Entrance, but
neither Replication nor Immunomodulation
during Infection of Human Primary Cells
The impact of pe_pgrs33 polymorphisms was further investigated
in vitro by infecting human monocyte-derived macrophages
(MDMs) isolated from healthy donors with the Mtb H37Rv,
TABLE 1 | Details of genetic variations for the 5 pe_pgrs33 alleles selected
in this study.
pe_pgrs33 allele Genetic variation Position (bp)
3 sSNP 582
sSNP 717
−1 bp 1,014
(+9 bp) (1,240)
5 nsSNP 697
sSNP 717
+9bp 1,240
6 −72 bp 416–487
sSNP 717
+9 bp 1,240
11 Nonea
18 sSNP 717
−42 bp 772–813
+9 bp 1,240
aNone compared to pe_pgrs33 gene of Mtb H37Rv (NC_000962.3). Each color has been
assigned to distinguish different alleles.
Mtb133 mutant and complemented strains at a MOI 1:1
(Figure 4). Mtb133::33all11 and Mtb133::33all5 were able to
complement the entry phenotype into MDMs compared to the
parental strain (Figure 4A). Similar to the Mtb133 mutant (p
< 0.01), Mtb133::33all3 (p < 0.001), Mtb133::33all6 (p < 0.05),
and Mtb133::33all18 (p < 0.05) were unable to fully restore
the ability of Mtb H37Rv to entry into macrophages. To assess
the impact of pe_pgrs33 polymorphisms on the capacity of Mtb
to replicate intracellularly, macrophages infected as above were
harvested at 72 h to determine CFUs and results expressed as
logarithmic ratio between intracellular CFUs at 72 and 4 h. As
shown in (Figure 4B), no statistically significant differences were
observed for the Mtb133 mutant and complemented strains
compared to Mtb H37Rv. Based on previous evidences on the
immune modulating properties of PE_PGRS33 (Basu et al.,
2007; Zumbo et al., 2013), two pro-inflammatory cytokines,
TNF-α and IL-1β, were evaluated by performing a cytometric
bead array (CBA) assay on supernatants collected at 72 h
from MDMs infection. In (Figure 5), results of TNF-α and
IL-1β levels are reported and show a reduced ability for the
Mtb133 mutant and complemented strains to elicit TNF-α
secretion compared toMtbH37Rv, even if this difference did not
reach statistical significance. To further assess whether pe_pgrs33
genetic polymorphisms could elicit peculiar phenotypes during
infection of human primary cells, in terms of replication capacity
of Mtb and modulation of host immune responses by the
pathogen, we used the panel of selected mycobacterial strains to
infect peripheral blood mononuclear cells (PBMC) isolated from
the same donors. Also in this cellular model, mycobacterial CFUs
enumerated at 72 h post-infection did not result in significant
differences in the replication capacity of all recombinant Mtb
strains compared to Mtb H37Rv (Figure 6A). Moreover, no
significant perturbations in the ability of Mtb to induce a
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FIGURE 2 | Schematic and details of amino acid variations in the 5 pe_pgrs33 alleles-encoded proteins selected in this study. Five pe_pgrs33 alleles
under the control of the respective native promoter were amplified and cloned upstream the HA epitope sequence into the integrative plasmid pMV306 (Palucci et al.,
2016). (A) Upper in the cartoon is schematized the protein encoded by 33all11 without natural mutations respect to PE_PGRS33 of Mtb H37Rv. Amino acid variations
occurring in the proteins encoded by 33all3, 33all5, 33all6, and 33all18 are indicated with different symbols (red dashed line, different amino acid composition due to a
frameshift mutation in the respective gene; red dot, single amino acid substitution; green triangle, amino acids inserted; red triangle, amino acids deleted). Cloning and
protein details are reported beside. (B) Protein lysates of the Mtb133 complemented strains were analyzed by western blot. Due to the frameshift deletion, the protein
encoded by 33all3 was undetectable with an anti-HA antibody and was thus not included in this analysis (cfr. Supplementary Figure 1 for control PCRs).
TNF-α, IL-1β, and IFN-γ-mediated proinflammatory response
were detected in PBMCs infections, althoughMtb133::33all3 and
Mtb133::33all5 showed a slight decreased capacity to induce
both TNF-α, and IL-1β (Figure 6B) secretion in line with what
observed in MDMs infections.
Major Genetic Variations in pe_pgrs33
Differently Affect Mtb Replication during
the Chronic Persistent TB Disease Stages
in Murine Infection Model
To assess the role of PE_PGRS33 on the virulence of Mtb, 5
groups of BALB/c mice were intranasally infected with Mtb
H37Rv, theMtb133mutant and 3 complemented strains selected
from those previously assessed in vitro, one expressing the allele
corresponding to pe_pgrs33 ofMtbH37Rv (Mtb133::33all11) and
two expressing pe_pgrs33 alleles characterized by major genetic
variations (Mtb133::33all3 and Mtb133::33all6) (Figure 7). At
day 0 post-infection, the number of CFUs enumerated in
murine lungs did not significantly vary, indicating that the Mtb
H37Rv, Mtb133 and complemented strains were similarly able
to infect mice. At day 28 post-infection, which is considered
the hallmark of active disease in mice, no variation of the
bacterial burden in the lungs was found for both Mtb133::33all6
and Mtb133 compared to the parental strain. Conversely, a
reduced bacterial load was detected for Mtb133::33all11 and for
Mtb133::33all3 strains compared to Mtb H37Rv. Interestingly,
at day 49 post-infection, lung CFUs from mice infected with
Mtb133 were higher (p < 0.05) than those from mice infected
with Mtb H37Rv and increased significantly (p < 0.001) from
the CFUs enumerated at day 28 post-infection, indicating that
the lack of PE_PGRS33 results in an enhanced ability of Mtb to
replicate/persist in the lung tissue of mice during the chronic
phases of the disease. A similar trend was also found for
Mtb133::33all3, with lung CFUs significantly higher at day 49
compared to day 28 post-infection (p < 0.01). Conversely,
bacterial loads were significantly reduced for Mtb133::33all11 (p
< 0.001) andMtb133::33all6 (p< 0.01) compared to the parental
strain at day 49 post-infection.
The Lack and Truncation of PE_PGRS33 in
Mtb Is Responsible for the Extent of Tissue
Damage in Murine Lungs during the
Chronic Persistent TB Disease Stages
For all 5 strains tested in in vivo infections (Mtb H37Rv,
Mtb133::33all11, Mtb133::33all3, Mtb133::33all6, and Mtb133),
both quantitative and qualitative histopathological examinations
were carried out on lung sections of mice sacrificed at day 28
and day 49 post-infection (Figure 8). At day 28 post-infection,
no major differences were observed between the Mtb strains
tested, in terms of number and extension of granulomas and
net pulmonary area with lesions (Figures 8A–C). Similarly, at
day 49 post-infection, apart from Mtb133::33all3 (p < 0.01)
and to a lesser extent Mtb133::33all6, no significant differences
were found between all other strains analyzed (Figures 8A–D).
However, a higher, but not significant number of granulomas was
enumerated for Mtb133::33all11, Mtb133::33all6, and Mtb133,
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FIGURE 3 | Frameshift mutation in pe_pgrs33 negatively affects the
protein-mediated entry of Mtb into murine macrophages. pMMOs were
infected at a MOI of 1:10 with Mtb H37Rv, the Mtb133 mutant and a panel of
complemented strains (Mtb133::33all11, Mtb133::33all3, Mtb133::33all5,
Mtb133::33all6, and Mtb133::33all18). For all Mtb strains, mean value of
CFUs in triplicate from a representative experiment of pMMOs infection and
the respective standard deviation are represented. **p < 0.01 and ***p <
0.001 compared to Mtb H37Rv (one-way ANOVA followed by Dunnett’s
multiple comparison test).
in particular, compared to the parental strain (Figure 8A).
Conversely, the lungs of mice infected with Mtb133::33all3 were
characterized by a reduction in the number of granulomas
compared with those of mice infected with Mtb H37Rv (p <
0.01; Figure 8A). Surprisingly, based on the size of granulomas
and net pulmonary area with lesions,Mtb133::33all3 causedmore
extensive tissue damage (p < 0.01) compared to the parental
strain, with major pulmonary confluent lesions which justify the
low number of granulomas detected in the lungs (Figures 8B,D).
At both day 28 and day 49 post-infection, the distribution
and percentage of cells with acid-fast bacilli was similar for all
analyzed strains, apart fromMtb133::33all3, which was associated
with a higher number of AFB compared to the parental strain
at day 49 post-infection. This last observation was consistent
with the features and extent of histopathological lesions shown
in Supplementary Figures 5, 6. Taken together, these results
suggest an interesting increased capacity of Mtb to evoke lung
tissue damage in murine model, when the PE_PGRS33 protein is
truncated or completely absent.
The Lack and Truncation of PE_PGRS33 Is
Responsible for the Extracellular
Localization of Mtb in Murine Lung Tissue
during the Chronic Persistent TB Disease
Stages
At higher magnification, lung sections from mice infected with
Mtb133, Mtb133::33all3, and Mtb133::33all6 were remarkably
characterized by a high number of foamy macrophages at
day 49 post-infection compared with the sections obtained
from the other groups of mice (Supplementary Figure 6).
Moreover, AFB positive cells remained stable in Mtb H37Rv,
Mtb133::33all11, Mtb133::33all6, and Mtb133 strains, but
Mtb133::33all3 showed a higher number of lesions, a reduced
percentage of positive cells and a high number of AFB found
extracellularly (Supplementary Figure 6). To better characterize
bacilli localization of Mtb133::33all3 compared to Mtb H37Rv
and Mtb133 in infected tissues, immunofluorescence was
performed by using two markers, anti-F4/80 and anti-MT 16
kDa antigen, to point out macrophages and bacilli, respectively.
The intra and extracellular position of bacilli was then evaluated
by comparing the results of immune-colocalization with those
obtained from observation of Ziehl-Neelsen (ZN)-stained lung
sections (Figure 9). As shown in Figure 9B, a yellow signal
was repeatedly observed in lung sections of mice infected
with Mtb H37Rv and derived from overlapping between red
and green signals, which label mycobacteria and macrophages,
respectively. An evident separation between the red and green
fluorescence of Mtb133::33all3 and macrophages, respectively,
revealed the predominant extracellular position of this strain
(Figure 9D). Also for Mtb133, it was demonstrated that the
two fluorescence signals were detected within the same area
although did not overlap regularly (Figure 9F). Moreover,
further differences, in terms of immune cells composition, were
also observed in lung tissue sections, as showed in ZN images
(Figures 9A,C,E). Particularly, a prevalence of macrophages and
some lymphocyte were found in lung tissue of mice infected
with Mtb H37Rv (Figure 9A). Similarly, lungs of mice infected
with both Mtb133::33all3 and Mtb133 were characterized by a
predominance of foamy macrophages, although the former also
contained apoptotic cells and the latter polymorphonuclear cells
(Figures 9C,E). These further investigations allowed to point
out a mainly extracellular localization for the Mtb133::33all3
and Mtb133 strains, showing how the lack or truncation of
PE_PGRS33 may affect the cellular localization ofMtb during the
chronic persistent TB disease stages.
DISCUSSION
Members of the MTBC show high homogeneity at genomic
level (99.9%), with most of the genetic variability resting on
two gene families, PE and PPE (Brennan and Delogu, 2002;
McEvoy et al., 2012; Copin et al., 2014; Fishbein et al., 2015).
Several genes of the PE_PGRS subfamily show high genetic
variability, including the pe_pgrs33 gene which was shown to
account for a wide heterogeneity of polymorphisms mainly
occurring in the PGRS domain (Talarico et al., 2005, 2007).
Sequence variations in this gene have been correlated with clinical
and epidemiological TB phenotypes (Talarico et al., 2007; Wang
et al., 2011), supporting the hypothesis that surface exposed
PE_PGRS proteins may be involved in antigenic variability (Cole
et al., 1998; Banu et al., 2002; Delogu et al., 2004). However,
despite several studies recognized the immunomodulatory role of
PE_PGRS33 (Dheenadhayalan et al., 2006; Balaji et al., 2007; Basu
et al., 2007), it remains still unclear whether and how pe_pgrs33
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FIGURE 4 | Large natural mutations in PE_PGRS33 impair entry, but do not affect the replication phenotype of Mtb H37Rv in in vitro human MDMs
infections. Human MDMs were infected at a MOI of 1:1 with Mtb H37Rv, the Mtb133 mutant and complemented strains (Mtb133::33all11, Mtb133::33all3,
Mtb133::33all5, Mtb133::33all6, and Mtb133::33all18). Mycobacterial entry and replication phenotypes were assessed by CFUs enumeration of intracellular
mycobacteria at 4 h (A) and 72 h post-infection, respectively. Logarithmic scale of CFUs ratio between intracellular mycobacteria at 72 and 4 h post-infection (B). For
all Mtb strains, mean value of CFUs in triplicate from MDMs infections of 4 donors and the respective standard deviation are represented. Bars indicate the median. *p
< 0.05, **p < 0.01, and ***p < 0.001 compared to Mtb H37Rv (Kruskal-Wallis one-way ANOVA followed by Dunnett’s multiple comparison test).
polymorphisms may affect the pathogenesis and virulence of
Mtb. To address this issue, we investigated the genetic variability
of pe_pgrs33 in a collection of 135 randomly selected MTBC
clinical isolates and assessed in in vitro and in vivo models the
impact of large sequence deletions on PE_PGRS33 function at
early and late phases ofMtb infection.
In our collection of 135 genotyped MTBC clinical isolates,
we identified 19 pe_pgrs33 alleles: 12 corresponded to alleles
already characterized in previous studies, including pe_pgrs33
of Mtb H37Rv, while the other 7 alleles were newly identified
in this study. As shown in Figure 1, where each MTBC clinical
strain was color-coded by the respective pe_pgrs33 allele, the
overall association observed between specific alleles and MTBC
superlineages or lineages suggests a clustering of pe_pgrs33
alleles during the evolution of Mtb. Moreover, we obtained
a dN/dS ratio of 0.64, which being below 1 indicates that
pe_pgrs33 is under a purifying selection. Contrary to the possible
involvement of PE_PGRS33 in the antigenic variability of Mtb
and in agreement with a recent work of Copin et al. (2014),
our results support the evidence that pe_pgrs33 is under a
biologic pressure to prevent polymorphisms, which may impair
the key functional role of this protein in the biology of Mtb.
Previous studies correlated naturally-occurring polymorphisms
in pe_pgrs33 with TB clinical features: genetic variations in this
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FIGURE 5 | Polymorphisms in pe_pgr33 do not affect the immunomodulatory properties of the protein in in vitro human MDMs infections. Supernatants
collected at 72 h post-infection were assessed for TNF-α and IL-1β. For all Mtb strains, each symbol corresponds to the mean of triplicates obtained from MDMs
infections of 4 healthy donors. Bars indicate the median. None statistically significant difference was observed compared to Mtb H37Rv (Kruskal-Wallis one-way
ANOVA followed by Dunnett’s multiple comparison test).
gene have been associated with TB meningitis in children (Wang
et al., 2011) and large in-frame indels and frameshift mutations
have been correlated with the absence of cavitation in the lungs
(Talarico et al., 2007). In these circumstances, it appears that
large polymorphisms in pe_pgrs33 do not affect the virulence of
Mtb, since TB in children and extrapulmonary TB may present
with severe clinical patterns, which, however, do not warrant an
efficient transmission of Mtb. Moreover, it is interesting to note
that the pe_pgrs33 gene is absent in the genome of M. marinum,
which contains more than 100 pe_pgrs genes (Delogu et al.,
2008), and in smooth tubercle bacilli (STB) (Supply et al., 2013),
suggesting that pe_pgrs33 belongs to the panel of genes that could
have been acquired by MTBC to gain additional virulence and
persistence mechanisms (Supply et al., 2013). Together, all of
these evidences suggest the potential critical role of pe_pgrs33 for
the successful transmission ofMtb in humans.
We recently characterized in vitro the Mtb mutant for
pe_pgrs33 (Mtb133), demonstrating that the lack of PE_PGRS33
results in a significant impairment of the Mtb entry capacity
into macrophages (Palucci et al., 2016), and proposed that
the binding of PE_PGRS33 to TLR2 may reasonably activate
the inside-out signaling, which contributes to the entry
of Mtb into macrophages (Palucci et al., 2016). In this
study, when the Mtb133 mutant strain was complemented
with plasmids encoding selected pe_pgrs33 alleles and these
Mtb strains were used to infect murine macrophages, we
observed complementation of the parental strain phenotype
with pe_pgrs33 alleles showing both small genetic variations and
large in-frame deletions. Conversely, the truncated PE_PGRS33
protein encoded by 33all3, which contained a frameshift mutation
as major variation, was responsible for an impaired ability of
Mtb133::33all3 to enter murine macrophages, similar to that
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FIGURE 6 | Mtb replication and immunomodulation is not impaired by pe_pgrs33 polymorphisms in PBMCs infections. PBMCs were infected at a MOI of
1:1 with Mtb H37Rv, the Mtb133 mutant and complemented strains (Mtb133::33all11, Mtb133::33all3, Mtb133::33all5, Mtb133::33all6, and Mtb133::33all18).
Mycobacterial replication was assessed by CFUs enumeration of total mycobacteria at 72 h post-infection (A). For each Mtb strain, mean value of CFUs obtained in
triplicate from PBMCs infection of all 4 donors and the respective standard deviation are reported. Bars indicate the median. Supernatants collected at 72 h
post-infection were assessed for TNF-α, IL-1β, and IFN-γ (B). For all Mtb strains, each symbol corresponds to the mean of triplicates obtained from PBMCs infections
of 3 or 4 healthy donors, depending on the cytokine panel. Bars indicate the median. For both CFUs and cytokine analysis, none statistically significant difference was
observed compared to Mtb H37Rv (Kruskal-Wallis one-way ANOVA followed by Dunnett’s multiple comparison test).
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FIGURE 7 | Large natural mutations in the pe_pgrs33 gene differently
affect the replication capacity of Mtb in murine lungs. To evaluate the
lung colonization and replication capacity of Mtb133 mutant strains
complemented with pe_pgrs33 alleles characterized by large genetic
variations (frameshift and in-frame deletions), 5 groups of BALB/c mice (4 mice
per group) were challenged via intranasal route with Mtb H37Rv, the Mtb133
mutant and complemented strains (Mtb133::33all11, Mtb133::33all3, and
Mtb133::33all6). CFUs in murine lungs were then enumerated at day 0, 28,
and 49 post-infection. For all Mtb strains, mean value of CFUs in quadruplicate
from a representative experiment of mice infection and the respective standard
deviation are represented. *p < 0.05, **p < 0.01, and ***p < 0.001 (two-way
ANOVA followed by Dunnett’s multiple comparison test).
one of the Mtb133 mutant (Palucci et al., 2016). In infection
of human macrophages, the Mtb strains expressing pe_pgrs33
alleles with large deletions did not fully restore the parental strain
phenotype and the defect in Mtb entry was again particularly
marked for Mtb133::33all3. Moreover, the replication capacity
of the Mtb133 and complemented strains during infection of
human macrophages and PBMCs was not affected by mutations
in pe_pgrs33 and the level of cytokines secreted by the innate
immunity were not perturbed at 72 h post-infection. These
results suggest that the absence of PE_PGRS33 or the presence
of mutations, which occur in the gene region encoding the PGRS
domain and determine an extensive and dramatic change in
the protein sequence and presumably structure, do not impact
the ability of Mtb to survive and multiply into macrophages.
Potential differences in the ability of PE_PGRS33 to interact
with cell surface receptors of murine and human macrophages,
probably due to the polymorphic nature of the variable region
of TLR2 (Grabiec et al., 2004), could explain the differences
observed between the two cell models used for infections,
although our hypothesis would require further investigations.
The role of PE_PGRS33 in the pathogenesis and virulence
of Mtb was also investigated in vivo by infecting mice via the
intranasal route and assessing the impact of major variations
(frameshift and in-frame deletions) occurring in pe_pgrs33, in
terms of bacterial burden and extent of tissue damage in murine
lungs at different time points. Compared to the parental strain,
no differences were observed in the ability of the Mtb133
mutant and complemented strains to colonize the lung tissue of
mice at day 0 post-infection, suggesting that the defect in the
macrophage cell entry phenotype observed in vitro particularly
for the Mtb133::33all3 and Mtb133 mutant strains does not
translate in an enhanced killing in vivo, during the early stages of
the infectious process. Surprisingly, while the replication capacity
of Mtb133 was comparable with those of Mtb H37Rv at day
28 post-infection, a significant higher bacterial burden in the
lung tissue of mice was observed in absence of PE_PGRS33 and
was accompanied by more extensive histopathological lesions
in the Mtb133 mutant compared to the parental strain at
day 49 post-infection. These results point toward a key role
of PE_PGRS33 in the immunopathogenesis of TB, specifically
during the chronic/persistent steps of the infectious process in
mice.
Interestingly, quantitative and qualitative histopathology
analysis of lung sections of mice infected with theMtb133::33all3
revealed a significant extension of lung tissue damage and lesions
even much more pronounced compared with those observed in
the lung tissue of mice infected with the Mtb133 mutant strain.
These results suggest that major variations, such as the frameshift
deletion expressed by the Mtb133::33all3, are associated with a
pattern of lung tissue damage and virulence phenotype similar,
if not more remarkable, to that observed with Mtb133 during
the chronic stages of the infectious process. These results further
highlight the impact that subtle changes in the expression
of PE_PGRS33 in host tissues may have on the pathogenesis
of TB.
In most cases, genetic deletions of highly conserved genes
negatively affect the bacterial virulence resulting in an attenuated
phenotype. However, a number of studies provided evidences
of an hypervirulent phenotype following infection with Mtb
mutant strains, wherein individual genes of different functional
classes and crucial for the bacilli have been disrupted (ten Bokum
et al., 2008). In this study, we observed that the disruption or
truncation of pe_pgrs33, a gene important in the pathogenesis
of Mtb, resulted in a phenotype with enhanced virulence of
the Mtb133 mutant and Mtb133::33all3 strains in the lungs
of mice at day 49 post infection. These results suggest a
role of PE_PGRS33 during the chronic/persistent phase of the
disease, similarly to what observed for PE_PGRS30 (Iantomasi
et al., 2012) and other PE_PGRSs (Kruh et al., 2010). These
unexpected and only apparently controversial results, when
compared with what observed in macrophages in vitro, deserve
further investigation in animal models known to better mimic
human TB (Orme and Basaraba, 2014). However, regarding the
enhanced virulence observed for the Mtb133::33all3 strain, we
do not think that the frameshift mutation in 33all3 results in a
loss of function for the entire PE_PGRS33 protein, but rather
we hypothesize that the frameshift allele, which we identified
exclusively among all Mtb strains of our collection belonging
to the ancient superlineage 1 or EAI, could represent the real
ancestral gene. In this perspective and from an evolutionary point
of view, allele variants of pe_pgrs33, including the gene of Mtb
H37Rv, may have evolved from the frameshift allele to trigger a
yet unidentified pattern of immunomodulation at local level in
the lung lesions that in human may be instrumental to promote
tissue damage and ultimately to the successful transmission of
Mtb to new hosts (Comas and Gagneux, 2011). Based on previous
evidences about the diversity of selective pressures acting on
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FIGURE 8 | The lack and truncation of PE_PGRS33 is responsible for an increased virulence phenotype of Mtb in lung tissue during the
chronic/persistentMtb infection in mice. Quantitative and qualitative histopathological analysis were performed on lung sections of mice infected with Mtb H37Rv,
the Mtb133 mutant and complemented strains (Mtb133::33all11, Mtb133::33all3, and Mtb133::33all6). At least six lung sections per mouse for all 5 groups were
analyzed in different points. Extent of tissue damage was assessed as: (A) number of granulomas; (B) average surface of granulomas; and (C) percentage of tissue
surface area with lesions with respect to total lung area. (D) Granuloma extension and distribution in lung tissue were evaluated after performing histopathological
analysis of lung sections stained with H&E at days 49 post-infection (200x magnification). Representative slides are shown. *p < 0.05 and **p < 0.01 (Student’s t-test).
pe_pgrs genes (Copin et al., 2014), in future studies, it would be
interesting to deepen the impact of pe_pgrs33 alleles during the
infectious process of Mtb, in the context of the respective native
strains.
PE_PGRS33 with its different polymorphisms, and lack
of PE_PGRS33 thereof, can affect the immunomodulatory
properties ofMtb in host tissues in at least two ways, particularly
during the chronic/persistent steps ofMtb infection when bacilli
loads are significant. First, direct interaction of PE_PGRS33 on
Mtb surface with TLR2 may impact the cytokine milieu within
the lesions and host cells viability (Dheenadhayalan et al., 2006;
Balaji et al., 2007; Basu et al., 2007; Zumbo et al., 2013), which
may clearly affect the inflammatory environment in the lesions.
Second, the defect of Mtb133 to enter in host macrophages
(Palucci et al., 2016) may result in a higher number of
extracellular bacilli, which are known to differentially modulate
host immune responses at the site of infection (Orme, 2014).
In this context, the phenotype observed in vivo for the Mtb133
mutant and complemented strains with 33all11, 33all3, and 33all6
point for a key role of this protein in the immunopathogenesis of
TB. However, given the results obtained in mice, characterization
of the immunomodulatory mechanisms responsible for the role
of PE_PGRS33 in TB pathogenesis shall preferentially be carried
on relevant human model of TB (Orme and Basaraba, 2014).
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FIGURE 9 | Mtb lacking PE_PGRS33 or expressing the truncated allele 3 mainly localizes extracellularly in murine lungs during the chronic/persistent
TB stages. Cellular localization of bacilli was investigated at day 49 post-infection on lung sections of mice infected with the Mtb H37Rv (A,B), Mtb133::33all3 (C,D)
and Mtb133 (E,F) strains, by performing immunofluorescence assay (B,D,F) and comparing results with those obtained from observation of ZN-stained lung sections
(A,C,E). Immunofluorescence was carried out by using anti-F4/80 and anti-MT 16 kDa antigen, as markers of macrophages (green) and bacilli (red), respectively.
Colocalization of macrophages and bacteria resulted in yellow signals. Representative images are shown.
Hence, while it remains to be elucidated how PE_PGRS33 affect
Mtb virulence in humans, the results of this study indicate that
the immunomodulatory properties of PE_PGRS33 impact on the
immunopathogenesis of TB.
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